Wow I'm speechless... Everything I did yesterday worked out great. 1847 Goedeker Inc. (GOED)-- Here we go Van! NYSE American - Nasdaq Real Time Price. Currency in USD $3.4700+0.2400 (+7.43)<-------
For Once Loyalty is Rewarded! ATOSSA 17 mil+ so far!! Atossa Therapeutics, Inc. (ATOS) $5.11+0.46 (+9.89%)<------------ As of 12:38PM EDT.
The stock market, like any other industry, is riddled with clichés. One of the most commonly used is the ubiquitous “buy the rumor, sell the news.” However, clichés are not clichés without reason (another cliché...) and the old maxim could perfectly describe last week’s performance of Atossa Therapeutics (ATOS) stock. Since the end of April, shares had more than tripled in anticipation of the final results from the phase 2 clinical trial evaluating oral endoxifen, the biotech’s breast cancer treatment to be administered between diagnosis and surgery. The company disclosed the results last week. With a 65.1% reduction in Ki-67 levels - a measure of tumor cell activity - the study met its primary endpoint. What’s more, all evaluated patients displayed a reduction of Ki-67 to levels below 25%, which shows the drug’s potential to improve long-term survival. The drug was also shown to be overall safe and well tolerated. Next up, the company said it has initiated a formal non-clinical toxicology program, a prerequisite for the New Drug Application to gain endoxifen’s entry to market. The company will also seek the FDA’s approval to move to the next stage of the clinical testing in the U.S. However, the shares dropped by 27% in the subsequent session, a clear case of the aforementioned "buy the rumor, sell the news,” says Maxim’s Jason McCarthy. “Bottom line, is the data are positive and that there are no options for women during this period before surgery, a time in which the tumor can/will continue to grow,” the 5-star analyst said. “Additionally, with $138M in cash on the balance sheet as of 1Q21, the company has several years of runway and as such, we are lowering our discount rate to 25%, from 30%. With this much capital, Atossa should be able to continue to develop endoxifen in later stages.” As a result, McCarthy also reduced the risk adjustment for endoxifen in the neoadjuvant breast cancer setting from 75% to 50%. The implication for investors? McCarthy rates ATOS shares a Buy alongside a $7 price target. Shares could appreciate ~51%, should the analyst’s thesis play out in the coming months. Only one other analyst is currently tracking Atossa’s progress, also believing the stock is a Buy, both coalescing a Moderate Buy consensus rating. The Moderate Buy consensus rating is backed by a $7.5 average price target.-!!
Atossa Therapeutics Set to Be Included in the Russell 2000 and Russell 3000 Indexes Atossa Therapeutics, Inc. Wed, June 16, 2021, 9:00 AM SEATTLE, June 16, 2021 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq:ATOS), a clinical stage biopharmaceutical company seeking to discover and develop innovative medicines in areas of significant unmet medical need with a current focus on breast cancer and COVID-19, today announced it is set to be added to the Russell 2000 and Russell 3000 Indexes This milestone will take place at the conclusion of the 2021 Russell Indexes’ annual reconstitution, effective after the U.S. market opens on June 28, 2021,
Dibs wants more! 1stdibs.Com, Inc. (DIBS) NasdaqGM - NasdaqGM Real Time Price. Currency in USD $24.89+1.97 (+8.60%) As of 12:44PM EDT.
Affirm Holdings, Inc. (AFRM)-hit $70.80 today! Next Stop $77 NasdaqGS - NasdaqGS Real Time Price. Currency in USD $69.56+2.14 (+3.18%)
This sounds like every other company- don't get it Description Squarespace, Inc. operates platform for businesses and independent creators to build online presence, grow their brands, and manage their businesses across the internet. The company offers websites, domains, e-commerce, tools for managing a social media presence, marketing tools, and scheduling capabilities. It serves small and medium-sized businesses, and independent creators, such as restaurants, photographers, wedding planners, artists, musicians, and bloggers. Squarespace, Inc. was founded in 2003 and is headquartered in New York, New York.
MAILBAG-- TRIPLE WITCH MAILBAG-- Dear Stoney- Could you talk a bit about Score Media? I bought when you did and it's my only stock up. I have quite a bit and am very happy but nervous for I don't know why it's looking so good. Thanks Jeremy D from L.A. Hi Jeremy-! I believe it is up for the reason I thought initially, I had done some detective work about when a certain bill that benefits them was going to be presented in Canada & the first time I misread everything and the actual vote did not happen just the entering of the bill. Whoops! I'm still not positive but I think the actual vote is today. The bill is called C218. Score Media and Gaming Inc. (SCR) NasdaqGS - NasdaqGS Real Time Price. Currency in USD $24.20+2.36 (+10.81%)<-------------